title: Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients.
abstract: The pharmacokinetics and pharmacodynamics of drugs are significantly altered in the burn patient, and the burn patient population shows wide inter- and intraindividual variation in drug handling. Burn injury evolves in two phases. The first phase corresponds to the burn shock, which occurs during the first 48 hours after thermal injury. In this phase, hypovolaemia, oedema, hypoalbuminaemia and a low glomerular filtration rate are observed, which result in a slower rate of drug distribution and lower renal clearance. The second phase (beyond 48 hours after injury) is a hyperdynamic state with high blood flow in the kidneys and liver, an increased alpha1-acid-glycoprotein level and loss of the drug with exudate leakage. As a result, protein binding, drug distribution and clearance may be altered. Because of the alteration in these variables, wide intraindividual variation of pharmacokinetic parameters occurs depending upon the time since thermal injury and fluid resuscitation. Interindividual variations may be correlated with the percentage of the body surface area that is burnt, creatinine clearance, albuminaemia or the alpha1-acid-glycoprotein level. A number of important variations in pharmacodynamic parameters have been described, but their mechanisms are poorly understood. From a practical point of view, for the subpopulation of burn patients who eliminate drugs extremely rapidly, higher doses and/or shorter dosing intervals are required to avoid treatment inefficacy. Drug concentration measurements help to take into account interindividual variability. However, adaptation of doses based on Bayesian methods is frequently not possible because the distribution of pharmacokinetic parameters is poorly characterized in this population. Methods based only on individual data or on a surrogate marker for efficacy may be used to optimize the dosing regimen in this population.
authors.affiliation: Department of Pharmacy-Toxicology, GH Cochin-Saint Vincent-de-Paul, Paris, France.
authors.forename: Benoit
authors.initials: B
authors.lastname: Blanchet
authors.forename: Vincent
authors.initials: V
authors.lastname: Jullien
authors.forename: Christophe
authors.initials: C
authors.lastname: Vinsonneau
authors.forename: Michel
authors.initials: M
authors.lastname: Tod
mesh_terms: D000700:Analgesics / Q000493:pharmacokinetics* / Q000494:pharmacology; D000777:Anesthetics / Q000493:pharmacokinetics* / Q000494:pharmacology; D000818:Animals; D000890:Anti-Infective Agents / Q000493:pharmacokinetics* / Q000494:pharmacology; D000897:Anti-Ulcer Agents / Q000493:pharmacokinetics* / Q000494:pharmacology; D000927:Anticonvulsants / Q000493:pharmacokinetics / Q000494:pharmacology; D002056:Burns / Q000503:physiopathology*; D016572:Cyclosporine / Q000493:pharmacokinetics / Q000494:pharmacology; D004334:Drug Administration Schedule; D006801:Humans; D007166:Immunosuppressive Agents / Q000493:pharmacokinetics / Q000494:pharmacology; D003473:Neuromuscular Nondepolarizing Agents / Q000493:pharmacokinetics* / Q000494:pharmacology; D010672:Phenytoin / Q000493:pharmacokinetics / Q000494:pharmacology
chemical_list: D000700:Analgesics; D000777:Anesthetics; D000890:Anti-Infective Agents; D000897:Anti-Ulcer Agents; D000927:Anticonvulsants; D007166:Immunosuppressive Agents; D003473:Neuromuscular Nondepolarizing Agents; D010672:Phenytoin; D016572:Cyclosporine
references.citation: J Burn Care Rehabil. 1990 Sep-Oct;11(5):391-4
references.pmid: 2246307
references.citation: Anesthesiology. 1989 May;70(5):752-5
references.pmid: 2719307
references.citation: J Trauma. 1976 Oct;16(10):824-8
references.pmid: 994263
references.citation: Clin Pharmacol Ther. 1988 Mar;43(3):250-5
references.pmid: 3345616
references.citation: Int J Clin Pharmacol Ther. 2007 Mar;45(3):133-42
references.pmid: 17416108
references.citation: Eur J Clin Pharmacol. 1999 Sep;55(7):515-9
references.pmid: 10501821
references.citation: Pathol Biol (Paris). 1987 May;35(5):603-7
references.pmid: 2956565
references.citation: Eur J Clin Pharmacol. 1989;36(4):361-7
references.pmid: 2737228
references.citation: J Clin Pharmacol. 1986 Feb;26(2):147-51
references.pmid: 3950058
references.citation: Am J Physiol. 1988 Nov;255(5 Pt 2):H1069-74
references.pmid: 3189570
references.citation: J Pharmacol Exp Ther. 1980 Apr;213(1):97-9
references.pmid: 7359372
references.citation: Clin Pharmacol Ther. 1992 Apr;51(4):408-14
references.pmid: 1563210
references.citation: Antimicrob Agents Chemother. 1996 Jan;40(1):139-45
references.pmid: 8787895
references.citation: Int J Antimicrob Agents. 2006 Sep;28(3):226-30
references.pmid: 16908121
references.citation: Presse Med. 1984 Mar 29;13(13):805-7
references.pmid: 6231599
references.citation: Anesthesiology. 1996 Mar;84(3):526-32
references.pmid: 8659779
references.citation: J Clin Pharmacol. 1990 Jul;30(7):632-7
references.pmid: 2391394
references.citation: J Clin Pharmacol. 2007 Jun;47(6):674-80
references.pmid: 17428913
references.citation: Pathol Biol (Paris). 1987 Jun;35(5 Pt 2):777-80
references.pmid: 3309814
references.citation: J Burn Care Rehabil. 2005 May-Jun;26(3):207-27
references.pmid: 15879742
references.citation: Arch Surg. 1983 Mar;118(3):295-302
references.pmid: 6824430
references.citation: J Trauma. 1976 Oct;16(10):819-23
references.pmid: 994262
references.citation: J Antimicrob Chemother. 1991 Nov;28(5):747-52
references.pmid: 1778877
references.citation: J Burn Care Rehabil. 1994 Mar-Apr;15(2):95-103
references.pmid: 8195267
references.citation: J Trauma. 1993 Sep;35(3):394-8
references.pmid: 8371297
references.citation: Clin Pharmacol Ther. 1990 Aug;48(2):130-7
references.pmid: 2379384
references.citation: Br J Clin Pharmacol. 2003 Dec;56(6):629-34
references.pmid: 14616422
references.citation: Burns. 2000 Feb;26(1):109-10
references.pmid: 10630329
references.citation: J Antimicrob Chemother. 1989 Nov;24 Suppl B:121-9
references.pmid: 2606814
references.citation: Antimicrob Agents Chemother. 1990 May;34(5):792-5
references.pmid: 2360818
references.citation: Drugs Exp Clin Res. 1989;15(4):177-84
references.pmid: 2776659
references.citation: Antimicrob Agents Chemother. 1999 Dec;43(12):2848-54
references.pmid: 10582870
references.citation: Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi. 1994 Sep;10(5):385-8
references.pmid: 7712387
references.citation: Anesthesiology. 1981 May;54(5):378-82
references.pmid: 7224206
references.citation: Clin Pharmacol Ther. 1984 Apr;35(4):535-9
references.pmid: 6705453
references.citation: J Burn Care Rehabil. 1989 Sep-Oct;10(5):425-8
references.pmid: 2793921
references.citation: Res Commun Chem Pathol Pharmacol. 1986 Oct;54(1):87-99
references.pmid: 3797808
references.citation: J Pharmacokinet Biopharm. 1976 Apr;4(2):183-95
references.pmid: 950590
references.citation: Br J Anaesth. 1992 Nov;69(5):447-50
references.pmid: 1467073
references.citation: Burns. 1993 Dec;19(6):529-30
references.pmid: 8292242
references.citation: Antimicrob Agents Chemother. 1993 May;37(5):1073-81
references.pmid: 8517694
references.citation: Scand J Infect Dis Suppl. 1990;72:29-34
references.pmid: 2151064
references.citation: Presse Med. 1994 Nov 5;23(34):1554-8
references.pmid: 7824489
references.citation: Ann Pharmacother. 2001 Dec;35(12):1588-92
references.pmid: 11793627
references.citation: J Trauma. 1982 Nov;22(11):944-9
references.pmid: 7143501
references.citation: Int J Clin Pharmacol Ther. 2007 Oct;45(10):529-38
references.pmid: 17966838
references.citation: Burns. 1996 Jun;22(4):255-74
references.pmid: 8781717
references.citation: N Engl J Med. 1978 Oct 26;299(17):915-9
references.pmid: 692596
references.citation: Eur J Clin Pharmacol. 1988;35(5):543-9
references.pmid: 3069478
references.citation: Ann Fr Anesth Reanim. 1989;8 Suppl:R157
references.pmid: 2604116
references.citation: J Dermatol. 1993 Apr;20(4):208-13
references.pmid: 8315110
references.citation: Antimicrob Agents Chemother. 1993 May;37(5):1065-72
references.pmid: 8517693
references.citation: J Antimicrob Chemother. 1997 Jun;39(6):677-86
references.pmid: 9222035
references.citation: Br J Clin Pharmacol. 2007 Jul;64(1):27-35
references.pmid: 17324245
references.citation: Antimicrob Agents Chemother. 1998 Apr;42(4):930-3
references.pmid: 9559811
references.citation: Antimicrob Agents Chemother. 1993 May;37(5):1132-6
references.pmid: 8517702
references.citation: Clin Pharmacol Ther. 1984 Aug;36(2):228-33
references.pmid: 6744781
references.citation: J Clin Pharmacol. 1990 Jan;30(1):70-5
references.pmid: 2303584
references.citation: Ann Fr Anesth Reanim. 1997;16(4):374-7
references.pmid: 9750583
references.citation: J Burn Care Rehabil. 1997 Mar-Apr;18(2):116-24
references.pmid: 9095420
references.citation: J Antimicrob Chemother. 2000 Mar;45(3):337-42
references.pmid: 10702553
references.citation: DICP. 1991 Jul-Aug;25(7-8):713-5
references.pmid: 1949924
references.citation: Ann Surg. 1980;192(4):570-80
references.pmid: 6775605
references.citation: Clin Pharmacol Ther. 1988 Jul;44(1):9-13
references.pmid: 3292106
references.citation: J Antimicrob Chemother. 2001 May;47(5):720
references.pmid: 11328796
references.citation: Pathol Biol (Paris). 1999 May;47(5):486-90
references.pmid: 10418024
references.citation: Anesth Analg. 1982 Mar;61(3):241-6
references.pmid: 7199837
references.citation: Anesth Analg. 1983 Mar;62(3):293-7
references.pmid: 6402956
references.citation: Acta Anaesthesiol Scand. 2005 Jan;49(1):85-91
references.pmid: 15675988
references.citation: Burns Incl Therm Inj. 1985 Oct;12(1):1-7
references.pmid: 4063865
references.citation: J Clin Pharmacol. 1986 Nov-Dec;26(8):680-5
references.pmid: 2947935
references.citation: J Antimicrob Chemother. 2000 Aug;46(2):315-7
references.pmid: 10933661
references.citation: J Burn Care Rehabil. 1990 Sep-Oct;11(5):410-8
references.pmid: 2246310
references.citation: Antimicrob Agents Chemother. 2006 Jun;50(6):1937-45
references.pmid: 16723549
references.citation: J Antimicrob Chemother. 1996 Mar;37(3):545-53
references.pmid: 9182111
references.citation: Clin Pharmacol Ther. 1977 Mar;21(3):362-9
references.pmid: 837654
references.citation: Antimicrob Agents Chemother. 1996 May;40(5):1153-6
references.pmid: 8723457
references.citation: Anesthesiology. 1986 Nov;65(5):517-20
references.pmid: 3777482
references.citation: Br J Clin Pharmacol. 1990 Dec;30(6):901-5
references.pmid: 2288837
references.citation: Antimicrob Agents Chemother. 1982 Sep;22(3):391-4
references.pmid: 7137982
references.citation: Fundam Clin Pharmacol. 2003 Dec;17(6):645-50
references.pmid: 15015709
references.citation: J Burn Care Rehabil. 1993 Nov-Dec;14(6):666-9
references.pmid: 8300702
references.citation: Antimicrob Agents Chemother. 1991 Jan;35(1):57-61
references.pmid: 2014982
references.citation: JAMA. 1985 Mar 1;253(9):1288-91
references.pmid: 3968854
references.citation: Therapie. 1986 Nov-Dec;41(6):417-20
references.pmid: 3810536
references.citation: Nouv Presse Med. 1979 Oct 31;8(42):3503-6
references.pmid: 537906
references.citation: Clin Pharmacol Ther. 1986 Jun;39(6):631-4
references.pmid: 3709027
references.citation: Surgery. 1978 Nov;84(5):603-8
references.pmid: 715674